Use of rifaximin and pharmaceutical formulations containing it i

Details Use of rifaximin and pharmaceutical formulations containing it i Use of rifaximin and pharmaceutical formulations containing it i

1993-06-28

1994-10-04

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3144

Patent

active

053526791

ABSTRACT:
The antibiotic known by the name rifaximin (INN) is active orally in the treatment of gastric dyspepsia caused by bacteria known as Helicobacter pylori. Rifaximin may be administered in any oral pharmaceutical form, particularly tablets, capsules, sugar coated tablets, granules and syrups containing from 200 to 2000 mg of active principle, at a daily dosage of between 400 and 2000 mg.

REFERENCES:
patent: 4341785 (1982-07-01), Marchi et al.

Affiliated with

Also associated with

Rating

Use of rifaximin and pharmaceutical formulations containing it i does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of rifaximin and pharmaceutical formulations containing it i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of rifaximin and pharmaceutical formulations containing it i will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-581455